Although novel ALK fusion variants have been occasionally reported in NSCLC, to our knowledge, the concomitance of double ALK fusion variants in the same lung adenocarcinoma (LUAD) patient was rare, by far, only 6 cases were reported, median age was 44 (range, 29–64 years). This evidence concerns the gene ALK and non-small cell lung carcinoma.